CompletedInterventionalNot ApplicableUpdated Feb 10, 2026
Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer | NCT00835055 | Trialant
WithdrawnObservationalUpdated Apr 5, 2019
Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer
ClinicalTrials.gov ID
NCT00835055
Lead Sponsor
St. Claraspital AGOTHER
Overall Status
Withdrawn
Study Type
Observational
Enrollment
0Actual
Last Update Posted
Apr 5, 2019Actual
Start Date
Apr 2005Actual
Primary Completion Date
Apr 1, 2019Actual
Completion Date
Apr 1, 2019Actual
Brief Summary
The purpose of this study is to determine whether markers on tumor tissue may be an indicator for good response to neoadjuvant chemoradiotherapy in patients with rectal cancer.